AS Tallink Grupp Unaudited Consolidated Interim Report Q3 2023
The Q3 2023 results of AS Tallink Grupp will be introduced at an Investor Webinar held today at 12:00 (EEST). To participate, please join via the following link; we kindly ask participants to provide their questions latest by 11:00 am by email to: firstname.lastname@example.org. Further details are available in a previously published announcement.
In the third quarter (1 July – 30 September) of the 2023 financial year, AS Tallink Grupp and its subsidiaries (the Group) carried 1 775 821 passengers, which is 6.2% less than in the third quarter of 2022. The number of cargo units transported decreased by 26.1% compared to the same period a year ago. The Group’s unaudited consolidated revenue amounted to EUR 240.7 million (EUR 255.6 million in Q3 2022), down by 5.8% year-on-year. Unaudited EBITDA was EUR 82.1 million (EUR 67.7 million in Q3 2022) and the unaudited net profit for the period was EUR 48.7 million (EUR 37.9 million in Q3 2022), up by 21.3% and 28.5%, respectively.
The following operational factors impacted the Group’s revenue and operating results in the third quarter of 2023:
- The volume of cargo and passenger transportation was impacted by less vessels in operations due to chartering and by 17% less trips made compared to the same period a year ago.
- The demand was also impacted by low consumer confidence levels, and weak economic environment in all Group’s core markets but also by global geopolitical instability.
- As at the end of the quarter the Group operated 15 vessels including 2 shuttle vessels, 2 cargo vessels and 4 cruise ferries as well as 5 vessels that were chartered out (3 vessels on long-term and 2 vessels on short-term charter). During the quarter, 2 charter agreements ended. The charter agreement of the Group’s vessel Romantika was terminated in September 2023 prior to the agreement’s expiration date. The short-term charter agreement of the cruise ferry Victoria I ended in July 2023.
- The planned dry docking of the cruise ferry Baltic Queen for 12 days in September 2023.
- The Group operated 3 hotels in Tallinn and 1 in Riga.
- Declining global fuel prices and the optimal fleet size had a positive impact on the Group’s cost base. However, while the fuel prices have dropped the fuel transportation cost component has increased.
- The Group’s net debt to EBITDA ratio was down to 2.7 as at 30 September 2023 compared to 3.1 as at 30 June 2023.
- The Group continues to focus on cost efficiency from previously implemented measures and retaining profitable operations on its core routes.
- The Group regularly monitors the developments on its core routes including the capacity of each route and continues to look for new chartering options for vessels not used on the main routes and to work on extending the existing chartering agreements.
Sales and Results by Segments
In the third quarter of 2023, the Group’s total revenue decreased by EUR 14.9 million to EUR 240.7 million compared to EUR 255.6 million in the third quarter of 2022.
Revenue from route operations (core business) amounted to EUR 195.7 million, which is EUR 15.1 million less than in the third quarter of 2022. The segment result from route operations (core business) amounted to EUR 55.0 million compared to EUR 39.1 million in the third quarter of 2022.
The number of passengers carried on the Estonia-Finland route decreased by 0.6% year-on-year. The number of transported cargo units decreased by 27.0%. While the revenue from the Estonia-Finland route decreased by EUR 7.1 million to EUR 86.4 million, the segment result improved by EUR 5.6 million to EUR 32.3 million. The decline in passenger numbers, cargo volumes and revenue were mostly driven by less vessels in operations and less trips made compared to the same period a year ago. In the third quarter of 2023, the segment reflects the operations of two shuttle vessels, compared to two shuttle vessels and one cruise ferry in the third quarter of 2022. The cruise ferry Silja Europa stopped operating on the Estonia-Finland route in August 2022 due to a charter agreement. During the third quarter of 2022, the Tallinn-Helsinki route was operated by the shuttle vessels Megastar and Oscar Wilde (formerly Star). The shuttle vessel Oscar Wilde stopped operating the route in May 2023 due to a charter agreement. In the third quarter of 2023, a route was operated by shuttle vessel Megastar and a new shuttle vessel MyStar that was launched to the Tallinn-Helsinki route in December 2022.
In the third quarter of 2023, the year-on-year decrease in the number of passengers on Finland-Sweden routes was 18.1%. The number of transported cargo units decreased by 41.0%. The routes’ revenue decreased by EUR 10.0 million to EUR 83.7 million while the segment result improved by EUR 8.0 million to EUR 18.9 million, year-on-year. The decline in passenger numbers, cargo volumes and revenue were mostly driven by less vessels in operations and less trips made compared to the same period a year ago. In the third quarter of 2023, the segment reflects the operations of one cruise ferry on Turku-Stockholm/Kapellskär routes and two cruise ferries on the Helsinki-Stockholm route. The cruise ferry Galaxy I stopped operating on the Turku-Stockholm route from September 2022 due to a charter agreement.
On Estonia-Sweden routes the number of carried passengers increased by 5.3% while the number of transported cargo units decreased by 1.1% compared to the third quarter of 2022. The revenue of Estonia-Sweden routes increased by EUR 2.0 million to EUR 25.5 million and segment result improved by EUR 2.3 million to EUR 3.9 million, year-on-year. Estonia-Sweden routes reflect the operation of two cargo vessels on the Paldiski-Kapellskär route and one cruise ferry on the Tallinn-Stockholm route.
Revenue from the segment Other increased by a total of EUR 0.6 million and amounted to EUR 47.4 million. The segment result declined year-on-year by EUR 5.2 million amounting to EUR 12.2 million. As at the end of third quarter 2023, the Group had 5 vessels on charter including 3 on long-term and 2 on short-term charter. During the quarter, the charter agreements of 2 vessels ended. The agreement for chartering out the cruise ferry Romantika, signed in March 2022, was terminated on 1 September 2023. The cruise ferry Victoria I, the charter agreement of which ended in July, started operating the Tallinn-Helsinki route on 12 October 2023.
In the third quarter of 2023, long-term charters included:
- The vessel Atlantic Vision was chartered to Canada in November 2008. The current agreement has been signed until May 2024 with an extension option for another 12 months.
- The shuttle vessel Oscar Wilde (formerly Star) was chartered out from 5 May 2023 for 20 months with the option of extending the charter by 2+2 year and the option of purchasing the shuttle.
- The cruise ferry Isabelle has been on long-term charter since 1 July 2023 and the charter agreement includes a purchase option.
In the third quarter of 2023, short-term charters included:
- The cruise ferry Galaxy I was chartered out in September 2022. In September 2023, the agreement was extended for six months until April 2024.
- The cruise ferry Silja Europa was chartered out in August 2022. In October 2023, the charter agreement was extended until the end of 2024.
In the third quarter of 2023, the Group’s gross profit improved by EUR 11.6 million to EUR 77.7 million compared to EUR 66.0 million in the third quarter of 2022. EBITDA improved by EUR 14.4 million and amounted to EUR 82.1 million.
Amortisation and depreciation expense increased by EUR 1.5 million to EUR 25.2 million compared to the third quarter of the financial year 2022.
As a result of increased interest rates and increased financing obligations related to the shuttle-vessel Mystar, net finance costs increased by EUR 2.1 million year-on-year to EUR 8.4 million in the third quarter of 2023.
The Group’s unaudited net profit for third quarter 2023 was EUR 48.7 million or EUR 0.065 per share compared to a EUR 37.9 million or EUR 0.051 per share in Q3 2022.
The Group’s investments in the third quarter of 2023 amounted to EUR 6.1 million.
Majority of the investments were related to the maintenance and repair works of the vessels. The cruise ferry Victoria I was prepared for operating a 22-hour cruise service between Tallinn and Helsinki from October 2023.
During the planned docking of the cruise ferry Baltic Queen both technical works as well as interior upgrades were carried out. The ferry’s propellers were re-bladed to enhance the speed of the ferry and to make the ferry more energy efficient. The expected fuel-saving from the re-blading is more than 13%. Additionally, the graphite paint was piloted on the cruise ferry Baltic Queen for hull painting to significantly reduce the water resistance of the vessel’s hull and thus increase the vessel’s efficiency.
At the end of the third quarter 2023, the Group’s net debt amounted to EUR 620.4 million, a decrease of EUR 44.5 million compared to the end of second quarter of 2023. The net debt to EBITDA ratio was 2.7 at the reporting date (3.1 as at 30 June 2023).
As at 30 September 2023, the Group’s cash and cash equivalents amounted to EUR 64.4 million (EUR 57.6 million as at 30 June 2023) and the Group had EUR 135.0 million in unused credit lines (EUR 135.0 million as at 30 June 2023). The total liquidity buffer (cash, cash equivalents and unused credit facilities) amounted to EUR 199.4 million (EUR 192.6 million as at 30 June 2023). In the third quarter of 2023, the Group repaid loans in the total amount of EUR 30.9 million compared to EUR 105.3 million in the second quarter of 2023. The current trade and other payables amounted to EUR 83.6 million (EUR 96.3 million as at 30 June 2023).
In 2018, the Group adopted a dividend policy subject to which dividends of a minimum amount of
EUR 0.05 per share would be paid if the economic performance enables it.
Due to continued global uncertainties the Annual General Meeting of Shareholders held on 13 June 2023 decided not to pay dividends for the financial year 2022.
Results of the first 9 months of 2023
In the first 9 months (1 January – 30 September) of the 2023 financial year, the Group carried 4.4 million passengers which is 4.8% more compared to the same period last year. The Group’s unaudited revenue for the period increased by 13.0% and amounted to EUR 641.6 million. Unaudited EBITDA for the first 9 months was EUR 177.7 million (EUR 85.4 million in January-September 2022) and unaudited net profit was EUR 76.7 million (net loss of EUR 2.8 million in January-September 2022).
The financial result of the first 9 months of 2023 was impacted by the following factors:
- The volume of cargo and passenger transportation was impacted by less vessels available due to chartering of vessels resulting in 12% less trips made compared to the same period a year ago.
- The chartering of vessels supporting the stability of cash flows.
- Planned maintenance works of 57 days which affected both the Finland-Sweden segment’s first quarter and the Estonia-Sweden segment’s third quarter passenger and cargo levels as well as the financial result.
- Repayment of long-term loans in the amount of EUR 155.5 million compared to EUR 71.0 million in 9 months 2022.
- The lower operating cost base compared to the same period in 2022 arising from chartering of vessels but also lower global fuel costs.
|For the period||Q3 2023||Q3 2022||Jan-Sep|
|Revenue (EUR million)||240.7||255.6||641.6||567.7|
|Gross profit/loss (EUR million)||77.7||66.0||168.9||71.6|
|EBITDA¹ (EUR million)||82.1||67.7||177.7||85.4|
|EBIT¹ (EUR million)||56.8||43.9||101.9||14.2|
|Net profit/loss for the period (EUR million)||48.7||37.9||76.7||-2.8|
|Depreciation and amortisation (EUR million)||25.2||23.7||75.7||71.2|
|Capital expenditures¹ ²(EUR million)||6.1||5.5||22.3||23.6|
|Weighted average number of ordinary shares outstanding||743 569 064||743 569 064||743 569 064||743 569 064|
|Earnings/loss per share¹ (EUR)||0.065||0.051||0.103||-0.004|
|Number of passengers||1 775 821||1 893 603||4 366 679||4 166 038|
|Number of cargo units||75 701||102 399||247 792||313 717|
|Average number of employees||4 756||5 256||4 878||5 048|
|Total assets (EUR million)||1 597.4||1 613.6||1 535.3||1 550.1|
|Total liabilities (EUR million)||813.7||878.4||845.1||897.8|
|Interest-bearing liabilities (EUR million)||684.8||722.5||711.5||746.5|
|Net debt¹ (EUR million)||620.4||664.9||608.7||655.9|
|Net debt to EBITDA¹||2.7||3.1||5.5||8.4|
|Total equity (EUR million)||783.7||735.2||690.2||652.3|
|Equity ratio¹ (%)||49%||46%||45%||42%|
|Number of ordinary shares outstanding||743 569 064||743 569 064||743 569 064||743 569 064|
|Shareholders’ equity per share (EUR)||1.05||0.99||0.93||0.88|
|Ratios¹||Q3 2023||Q3 2022||Jan-Sep|
|Gross margin (%)||32.3%||25.8%||22.8%||1.8%|
|EBITDA margin (%)||34.1%||26.5%||23.8%||5.7%|
|EBIT margin (%)||23.6%||17.2%||11.3%||-9.5%|
|Net profit/loss margin (%)||20.2%||14.8%||7.0%||-13.0%|
1 Alternative performance measures based on ESMA guidelines are disclosed in the Alternative Performance Measures section of this Interim Report.
2 Does not include additions to right-of-use assets.
EBITDA: result from operating activities before net financial items, share of profit of equity-accounted investees, taxes, depreciation and amortization
EBIT: result from operating activities
Earnings/loss per share: net profit or loss/ weighted average number of shares outstanding
Equity ratio: total equity / total assets
Shareholder’s equity per share: shareholder’s equity / number of shares outstanding
Gross profit/loss margin: gross profit / net sales
EBITDA margin: EBITDA / net sales
EBIT margin: EBIT / net sales
Net profit/loss margin: net profit or loss / net sales
Capital expenditure: additions to property, plant and equipment – additions to right-of-use assets + additions to intangible assets
ROA: earnings before net financial items, taxes 12-months trailing / average total assets
ROE: net profit 12-months trailing / average shareholders’ equity
ROCE: earnings before net financial items, taxes 12-months trailing / (total assets – current liabilities (average for the period))
Net debt: interest-bearing liabilities less cash and cash equivalents
Net debt to EBITDA: net debt / EBITDA 12-months trailing
Consolidatedstatement of profitor loss and othercomprehensiveincome
|Unaudited, in thousands of EUR||Q3 2023||Q3 2022||Jan-Sep|
|Revenue (Note 3)||240 668||255 555||641 588||567 726|
|Cost of sales||-163 013||-189 536||-472 682||-496 090|
|Gross profit/loss||77 655||66 019||168 906||71 636|
|Sales and marketing expenses||-10 399||-9 455||-30 781||-27 397|
|Administrative expenses||-11 175||-12 156||-37 494||-35 050|
|Impairment loss on receivables|
|Other operating income||789||-463||1 382||5 112|
|Other operating expenses||-35||0||-68||-84|
|Result from operating activities||56 835||43 945||101 945||14 217|
|Finance income (Note 4)||133||-133||804||48|
|Finance costs (Note 4)||-8 507||-6 188||-26 803||-17 847|
|Share of profit/loss of equity-accounted investees||0||0||0||0|
|Profit/loss before income tax||48 461||37 624||75 946||-3 582|
|Net profit/loss for the period||48 683||37 872||76 708||-2 788|
|Net profit/loss for the period attributable to equity holders of the Parent||48 683||37 872||76 708||-2 788|
|Other comprehensive income|
|Items that may be reclassified to profit or loss|
|Exchange differences on translating foreign operations||-244||43||29||491|
|Other comprehensive income for the period||-244||43||29||491|
|Total comprehensive profit/loss for the period||48 439||37 915||76 737||-2 297|
|Total comprehensive profit/loss for the period attributable to equity holders of the Parent||48 439||37 915||76 737||-2 297|
|Basic and diluted profit/loss per share (in EUR, Note 5)||0.065||0.051||0.103||-0.004|
Consolidatedstatement of financialposition
|Unaudited, in thousands of EUR||30.09.2023||30.09.2022||31.12.2022|
|Cash and cash equivalents||64 433||102 813||114 935|
|Trade and other receivables||34 577||39 988||31 380|
|Prepayments||11 485||14 522||9 379|
|Prepaid income tax||1||1||37|
|Inventories||39 758||39 757||39 965|
|Current assets||150 254||197 081||195 696|
|Investments in equity-accounted investees||75||165||75|
|Other financial assets and prepayments||4 510||3 377||3 622|
|Deferred income tax assets||21 840||21 840||21 840|
|Property, plant and equipment (Note 6)||1 391 682||1 279 659||1 438 286|
|Intangible assets (Note 7)||28 734||32 878||31 823|
|Non-current assets||1 447 141||1 338 219||1 495 946|
|TOTAL ASSETS||1 597 395||1 535 300||1 691 642|
|LIABILITIES AND EQUITY|
|Interest-bearing loans and borrowings (Note 8)||126 148||249 707||165 049|
|Trade and other payables||83 593||85 257||86 934|
|Payables to owners||6||6||6|
|Income tax liability||35||47||35|
|Deferred income||45 237||48 299||44 222|
|Current liabilities||255 019||383 316||296 246|
|Interest-bearing loans and borrowings (Note 8)||558 659||461 765||688 465|
|Non-current liabilities||558 659||461 765||688 465|
|Total liabilities||813 678||845 081||984 711|
|Share capital (Note 9)||349 477||349 477||349 477|
|Reserves||67 694||66 885||66 363|
|Retained earnings||365 883||273 194||290 428|
|Equity attributable to equity holders of the Parent||783 717||690 219||706 931|
|Total equity||783 717||690 219||706 931|
|TOTAL LIABILITIES AND EQUITY||1 597 395||1 535 300||1 691 642|
Consolidatedstatement of cashflows
|Unaudited, in thousands of EUR||Q3 2023||Q3 2022||Jan-Sep|
|CASH FLOWS FROM OPERATING ACTIVITIES|
|Net profit/loss for the period||48 683||37 872||76 708||-2 788|
|Adjustments||33 283||29 671||100 721||88 590|
|Receivables and prepayments related to operating activities||2 480||5 254||-5 282||-14 602|
|Inventories||2 496||4 736||207||-5 126|
|Liabilities related to operating activities||-27 274||-17 051||-2 703||21 033|
|Changes in assets and liabilities||-22 298||-7 061||-7 778||1 305|
|Cash generated from operating activities||59 668||60 482||169 651||87 107|
|Income tax repaid/paid||-20||-39||-111||-115|
|NET CASH FROM/USED OPERATING ACTIVITIES||59 648||60 443||169 540||86 992|
|CASH FLOWS FROM INVESTING ACTIVITIES|
|Purchase of property, plant, equipment and intangible assets (Notes 6, 7)||-6 083||-5 500||-22 249||-23 633|
|Proceeds from disposals of property, plant, equipment||164||-38||244||2 743|
|Proceeds from other financial assets||0||0||0||0|
|NET CASH USED IN INVESTING ACTIVITIES||-5 786||-5 534||-21 201||-20 884|
|CASH FLOWS FROM FINANCING ACTIVITIES|
|Proceeds from loans received (Note 8)||0||0||0||0|
|Repayment of loans received (Note 8)||-30 858||-25 042||-155 477||-71 030|
|Repayment of bonds (Note 8)||0||0||0||0|
|Change in overdraft (Note 8)||-15||-6 481||-15||11 646|
|Payments for settlement of derivatives||0||0||0||0|
|Payment of lease liabilities (Note 8)||-8 219||-4 332||-17 025||-12 844|
|Interest paid||-7 982||-6 548||-25 212||-18 022|
|Payment of transaction costs related to loans||0||-298||-1 112||-601|
|Dividends paid (Note 10)||0||0||0||0|
|Issue of shares||0||0||0||0|
|Income tax on dividends paid||0||0||0||0|
|NET CASH FROM/USED IN FINANCING ACTIVITIES||-47 074||-42 701||-198 841||-90 851|
|TOTAL NET CASH FLOW||6 788||12 208||-50 502||-24 743|
|Cash and cash equivalents at the beginning of period||57 645||90 605||114 935||127 556|
|Change in cash and cash equivalents||6 788||12 208||-50 502||-24 743|
|Cash and cash equivalents at the end of period||64 433||102 813||64 433||102 813|
Investor Relations Manager
AS Tallink Grupp
10111 Tallinn, Estonia
AttachmentsTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Resultat af auktion over skatkammerbeviser 29. november 202329.11.2023 10:25:38 CET | pressemeddelelse
Bud, salg, skæringsrenter og pris fremgår af nedenstående oversigt: ISINBud mio. kr. (nominelt)SalgSkæringsrente (pct.)Pro-rataKurs98 19237 SKBV 24 / I1.220 960 3,500 100 %99,1230 98 19310 SKBV 24 / II1.760 1.020 3,450 100 %98,2580 I alt2.980 1.980 Salget bliver afviklet den 1. december 2023
Result of the auction of treasury bills on 29 November 202329.11.2023 10:25:38 CET | Press release
Bids, sales, stop-rates and prices are presented in the table below: ISINBid Mill. kr. (nominal)SaleStop-rate (per cent)Pro-rataPrice98 19237 DKT 01/03/24 I1,220960 3.500 100 %99.1230 98 19310 DKT 03/06/24 II1,760 1,020 3.450 100 %98.2580 Total2,980 1,980 The sale will settle 1 December 2023
Dassault Aviation Wins Choiseul “Strategic Company” Award29.11.2023 10:21:57 CET | Press release
Dassault Aviation Wins Choiseul “Strategic Company” Award (Saint-Cloud, November 29, 2023) – Dassault Aviation is particularly proud to have received the 2023 Strategic Company Award as part of the Institut Choiseul’s Sovereignty Initiative. The institute believes that strategic companies represent one of the many facets of national strength. Award recipients are known for their capacity to effectively mobilize resources and know-how, and to provide solutions that meet national priorities. They are a cornerstone of French strategic heritage. Dassault Aviation is an industrial architect and complex systems integrator, a developer of strategic technologies, a major national exporter, a core shareholder of the Thales Group and a vital player in an industrial landscape that includes hundreds of business and service partners. The company is at the core of the French sovereign defense ecosystem. Dassault Aviation is also the only non-American company that manufactures high-end business jets.
Company announcement no 17/2023 Interim Report Q3 202329.11.2023 10:20:00 CET | Press release
Interim Report Q3 2023 EBITDA fixed herd prices (FHP) for Q3 2023 increased to 13.663 mEUR (Q3 2022: 10.463 kEUR), corresponding to an EBITDA margin FHP of 36.3% (Q3 2022: 32.5%). The quarterly EBITDA in Q3 2023 increased by 3.201 kEUR (compared to Q3 2022). Nevertheless, this consist of many parts this quarter: Russia harvest negative with 2,7 mEUR (from 4,1 to 1,5 mEUR) whereas remaining Russian business compensate positive with 3,0 mEUR partly due to FX (cost in EUR lower), Lithuania negative effects from one-off subsidy in Q3 2022 (2,5 mEUR), but combined sales/feed with positive effect of 4.9 mEUR and lower cost levels with 0.5 mEUR driven by utilities. Sales prices combined down, as they in Q3 2023 were 1.59 EUR/kg live weight, down from 1.62 EUR/kg Q2 2022 equal to EUR 0,8m, but EURRUB effects this picture highly as Lithuanian sales prices in EUR is up 23% and Russian in RUB is up 13%. Feed prices in Q3 2023 were 261 EUR/T (compared to 332 EUR/T Q3 2022). End September 2023 on h
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®29.11.2023 10:00:00 CET | Press release
The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® (golimumab) in healthy adult subjects, met its primary endpoint Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab). The study, which assessed the pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi in healthy adult subjects, met its primary endpoints. “These results demonstrate the strength of our platform approach to biosimilars development and manufacture, combining a well-designed and executed clinical study with the design of a high-quality manufacturing process and strong analytical capabilities,” said Joseph McClellan, Chief Scientific Officer. “As we progress more biosimilar candidates through clinical development and approval, w